Results 101 to 110 of about 1,160,518 (299)
Molecular Oncology, EarlyView.Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Molecular Oncology, EarlyView.Here, we demonstrate that HS1BP3 interacts with Cortactin through a proline‐rich region (PRR3.1) and show that this interaction, and HS1BP3 itself, promote cancer cell proliferation and invasion. Inhibition of this interaction leads to build‐up of TKS5 in multivesicular endosomes and altered secretion of CD63 and CD9, providing an explanation for the ...
Arja Arnesen Løchen +9 more
wiley +1 more source
South African Family Practice, 2006 No abstract available.
Pierre J.T. de Villiers
doaj +1 more source
The deconstructed journal – a new model for academic publishing
, 1999 The limitations of existing proposed and operational publishing models intended to replace the academic journal are briefly reviewed. Three ‘insights’ are described, the first is into the ‘means/end’ confusion of much current net-based publishing ...
Smith, John W.T., Smith, John W T
core
Open Access Publishing Bibliografie Österreich [PDF]
, 2012 The Austrian Open Access Publishing Bibliography includes articles about Open Access Publishing in Austria and articles of Austrian authors about Open Access Publishing that are indexed in DABI – Datenbank Deutsches Bibliothekswesen (http://dabi.ib.hu ...
Bauer, Bruno
core
The Essence and Transcendence of Scientific Publishing [PDF]
Frontiers in Research Metrics and Analytics, 2022 José L. Medina-Franco +2 more
openaire +3 more sources
Molecular Oncology, EarlyView.Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
, 2017 This is a short introduction to KIT Scientific Publishing that Regine Tobias (Head of publishing and media services at the library of Karlsruhe Institute of Technology) gave at the First Conference of the Association of European University Presses (AEUP).
Tobias, Regine, Tobias, Regine (5298301)
core +1 more source
Molecular Oncology, EarlyView.Radiotherapy (RT) response depends on the DNA repair capacity of tumor and host cells. We show that circulating tumor cell (CTC) counts and apoptosis rates before and after RT predict treatment response and outcome, which can be accessed via easily accessible liquid biopsy approaches. Created in BioRender. Wikman, H.
Yvonne Goy +10 more
wiley +1 more source
Molecular Oncology, EarlyView.This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska +13 more
wiley +1 more source